Holoxan

 

Topic mentions per year

Topic mentions per year

1976-2015
01219762015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
UNLABELLED This study evaluates histological response, long-term outcome, and toxicity in an intensive chemotherapy program given… (More)
Is this relevant?
1998
1998
Ifosfamide induced dominant lethal mutations in spermatozoa of mice at doses of 200 and 300 mg/kg and in spermatids and… (More)
Is this relevant?
1990
1990
An ongoing trial of combination chemotherapy using ifosfamide (Holoxan), epirubicin and 5-fluorouracil was started in 1987. A… (More)
  • table 3
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
1989
1989
The alkylating agent ifosfamide synthesized according to own method at the Institute of Pharmaceutical Industry, Warsaw, was… (More)
Is this relevant?
1989
1989
The efficacy of combined chemotherapy of Vepesid + Holoxan +/- Adriblastin as third-choice was studied in advanced testicular… (More)
Is this relevant?
1986
1986
The bioavailability of oral N,3-bis(2-chloroethyl) tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide (ifosfamide) (500-mg… (More)
Is this relevant?
1981
1981
Urotoxic side effects, especially hemorrhagic cystitis, have so far been a limiting factor in the therapeutic use of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
1979
1979
The so-called cystitis due to cyclophosphamide (Cytoxan) is caused by direct contact of the mucosa with alkylating metabolites in… (More)
Is this relevant?
1977
1977
Clinical experiences obtained until now in the treatment of 47 patients with small cell carcinoma of the bronchus with Holoxan… (More)
Is this relevant?
1976
1976
In cooperative studies performed in 21 German clinics, the new cytostatic agent 3-(2-chloroethyl)-2-[(2-chloroethyl)-amino… (More)
Is this relevant?